SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Intel Corporation (INTC) -- Ignore unavailable to you. Want to Upgrade?


To: slacker711 who wrote (183399)2/3/2006 11:54:58 AM
From: TimF  Respond to of 186894
 
OT

I think that in the short run you might get better consumer prices in America, but that would be a very short run. In the medium term things would probably be worse, you would get less investment in new drugs, and other problems, possibly including drug shortages due to the price limits. In the long run things could be better (at least for Americans), if the foreign industrialized countries drop their price controls or at least significantly loosen them. This would effectively end the subsidy Americans pay in higher price controls. The world average price for prescription drugs might go up, but the price Americans pay would probably go down. If foreign companies keep their price controls than either they will try to stamp out the export of drugs back to the US, or the American companies will export less drugs, or American will effectively import the price controls and investment in new drugs will decline perhaps drastically.

Tim